| Manager | Title | Age | Since |
|---|---|---|---|
Kirk Chin Kee
CEO | Chief Executive Officer | 64 | 2000-02-14 |
Woon Wui Chiew
DFI | Director of Finance/CFO | 52 | 2023-12-31 |
Mei Ling Wong
IRC | Investor Relations Contact | - | 2008-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kirk Chin Kee
CHM | Chairman | 64 | 2010-05-18 |
Robert Millner
BRD | Director/Board Member | 75 | 2000-02-22 |
Kirk Chuen Kee
BRD | Director/Board Member | 61 | 2016-05-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/7/26 | Others | Chief Executive Officer | 5,700,000 | 0.7890% | ||
| 1/7/26 | Others | Chief Executive Officer | 4,035,800 | 0.5586% | ||
| 1/7/26 | Others | Chief Executive Officer | 2,979,372 | 0.4124% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 481M | ||
| -0.31% | -0.92% | +13.95% | +95.02% | 101B | ||
| -1.08% | -2.29% | +43.27% | +150.14% | 50.99B | ||
| -0.39% | +1.19% | -14.67% | +273.72% | 20.76B | ||
| -0.25% | +0.75% | -10.70% | -11.54% | 7.93B | ||
| -1.66% | -0.15% | -37.55% | -38.65% | 6.81B | ||
| -0.33% | +1.72% | -0.40% | +17.65% | 6.79B | ||
| +0.13% | -1.39% | -18.80% | -33.78% | 5.92B | ||
| +0.67% | +0.91% | -2.75% | +23.98% | 4.96B | ||
| -2.94% | -1.73% | +18.27% | +22.13% | 4.11B | ||
| Average | -0.61% | +1.50% | -1.04% | +55.41% | 23.26B | |
| Weighted average by Cap. | -0.56% | -0.52% | +13.94% | +108.52% |
Employees
-
Sector
Pharmaceuticals
















